|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Apple will probably lose sales, but the impact to its overall financial results probably won't be significant.
Not all tech stocks are created equal. Emerging market investors know this well, since until recently their exposure was mostly limited to the supply chain, not shoot-for-the-stars names like Alibaba. ...
AbbVie and Pfizer both have great dividends and successful track records over the long run. But which is the better pick now?